Medicare Enrolled
Dr. Laurie Bresee
Nurse Practitioner - Family · Fairfield, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bresee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bresee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bresee
Dr. Laurie Bresee is a nurse practitioner - family in Fairfield, CA, with 7 years of NPI registration. Based on federal Medicare data, Dr. Bresee performed 21,646 Medicare services across 521 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bresee received a total of $11,784 from 58 pharmaceutical and/or device companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bresee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 7 years in practice
▲ Top 1% volume in CA
$11,784 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,646
Medicare services
Top 1% in CA for nurse practitioner - family
521
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,092 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,770 | $0 | $3 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 4,200 | $0 | $0 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,330 | $6 | $24 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
366 | $7 | $8 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
325 | $8 | $22 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
228 | $47 | $198 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
117 | $9 | $38 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
93 | $82 | $287 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
70 | $90 | $343 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
38 | $41 | $191 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
35 | $9 | $36 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
31 | $12 | $62 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
29 | $0 | $2 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $51 | $283 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
64.2% high complexity
30.7% medium
5.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,784
Total received (2022-2024)
Avg $3,928/year across 3 years
Top 1% in CA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
528
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,326 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$458 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,296
2023
$4,398
2022
$3,089
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$842
Novartis Pharmaceuticals Corporation
$353
PFIZER INC.
$347
Genentech USA, Inc.
$318
Lilly USA, LLC
$261
ABBVIE INC.
$235
Eisai Inc.
$174
Daiichi Sankyo Inc.
$135
Janssen Biotech, Inc.
$132
Regeneron Healthcare Solutions, Inc.
$131
Astellas Pharma US Inc
$110
Merck Sharp & Dohme LLC
$105
Takeda Pharmaceuticals U.S.A., Inc.
$87
Celgene Corporation
$82
SOBI, INC
$81
E.R. Squibb & Sons, L.L.C.
$79
Ipsen Biopharmaceuticals, Inc
$78
ARRAY BIOPHARMA INC
$74
Rigel Pharmaceuticals, Inc.
$72
SERVIER PHARMACEUTICALS LLC
$71
Pharmacosmos Therapeutics Inc.
$70
Agios Pharmaceuticals, Inc.
$60
SpringWorks Therapeutics, Inc.
$49
SUN PHARMACEUTICAL INDUSTRIES INC.
$48
Incyte Corporation
$47
Coherus Biosciences Inc.
$45
GENZYME CORPORATION
$42
Blueprint Medicines Corporation
$33
ADC Therapeutics America, Inc.
$28
Mirati Therapeutics, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$26
BioMarin Pharmaceutical Inc.
$24
Sumitomo Pharma America, Inc.
$17
Gilead Sciences, Inc.
$16
Top 3 companies account for 35.9% of 2024 payments
All-time payments by company (2022-2024) ›
AstraZeneca Pharmaceuticals LP
$1,571
Novartis Pharmaceuticals Corporation
$885
Genentech USA, Inc.
$774
Daiichi Sankyo Inc.
$708
Amgen Inc.
$687
PFIZER INC.
$603
Seagen Inc.
$529
Astellas Pharma US Inc
$482
Lilly USA, LLC
$467
ABBVIE INC.
$391
Merck Sharp & Dohme LLC
$371
Janssen Biotech, Inc.
$358
Celgene Corporation
$335
Takeda Pharmaceuticals U.S.A., Inc.
$334
Eisai Inc.
$264
E.R. Squibb & Sons, L.L.C.
$242
GlaxoSmithKline, LLC.
$204
Regeneron Healthcare Solutions, Inc.
$174
GENZYME CORPORATION
$166
SERVIER PHARMACEUTICALS LLC
$164
Ipsen Biopharmaceuticals, Inc
$163
SOBI, INC
$158
Coherus Biosciences Inc.
$122
ARRAY BIOPHARMA INC
$118
Incyte Corporation
$95
Rigel Pharmaceuticals, Inc.
$94
Kite Pharma, Inc.
$84
Blueprint Medicines Corporation
$70
Pharmacosmos Therapeutics Inc.
$70
Bayer Healthcare Pharmaceuticals Inc.
$70
ADC Therapeutics America, Inc.
$62
Gilead Sciences, Inc.
$62
TAIHO ONCOLOGY, INC.
$61
Agios Pharmaceuticals, Inc.
$60
Sobi, Inc
$52
Organon LLC
$51
EISAI INC.
$51
EMD Serono, Inc.
$50
SpringWorks Therapeutics, Inc.
$49
Alexion Pharmaceuticals, Inc.
$48
SUN PHARMACEUTICAL INDUSTRIES INC.
$48
Mirati Therapeutics, Inc.
$46
MorphoSys, US Inc.
$39
JAZZ PHARMACEUTICALS INC.
$38
TerSera Therapeutics LLC
$35
Pharmacyclics LLC, an AbbVie Company
$30
Pharmacyclics LLC, An AbbVie Company
$26
BioMarin Pharmaceutical Inc.
$24
Karyopharm Therapeutics Inc.
$24
Myriad Genetic Laboratories, Inc.
$24
Servier Pharmaceuticals LLC
$23
Janssen Pharmaceuticals, Inc
$20
G1 Therapeutics, Inc.
$19
Foundation Medicine, Inc.
$19
CTI BioPharma Corp.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Sumitomo Pharma America, Inc.
$17
Sun Pharmaceutical Industries Inc.
$15
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADVATE · AKEEGA · ALPROLIX · AYVAKIT · BLENREP · BOSULIF · BRAFTOVI · Bavencio · Blincyto · CABLIVI · CALQUENCE · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Enhertu · FRUZAQLA · Fabhalta · IBRANCE · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYRISK · NINLARO · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Perjeta · Phesgo · Polivy · Pomalyst · REBLOZYL · RETEVMO · ROCTAVIAN · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SYNAGIS · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONVENDI · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in CA.
Geographic Context
Family nurse practitioners within 10 mi
457
Per 100K population
101.4
County median income
$99,994
Nearest hospital
NORTHBAY MEDICAL CENTER
6.6 mi
6.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bresee is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 1% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bresee experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Bresee performed 13,770 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bresee receive payments from pharmaceutical companies?
Yes. Dr. Bresee received a total of $11,784 from 58 companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bresee's costs compare to other family nurse practitioners in Fairfield?
Dr. Bresee's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bresee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Fairfield
Browse family nurse practitioners in Fairfield ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in CA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in CA
Which CA family nurse practitioners receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology